This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Hologic Q4 Earnings Lag, Revenues Top, Stock Down in Aftermarket
by Zacks Equity Research
HOLX's fiscal 2024 fourth-quarter results underscore the durable growth of its businesses.
Encompass Health Q3 Earnings Beat on Higher Discharges, Stock Up 6.3%
by Zacks Equity Research
EHC's third-quarter results benefit from improved patient discharges. Higher operating expenses act as a partial offset.
Ensign Group Q3 Earnings Beat on Patient Days, Stock Up 4.1%
by Zacks Equity Research
ENSG's strong third-quarter earnings benefit from improved occupancy and skilled mix days. Higher expenses partially offset the positives.
Intuitive Surgical, Inc. (ISRG) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to Intuitive Surgical (ISRG). This makes it worthwhile to examine what the stock has in store.
Teleflex Q3 Earnings Top, Stock Falls on Lowered 2024 Revenue Outlook
by Zacks Equity Research
TFX benefits from a diversified product portfolio in the third quarter of 2024, with strength in the Vascular Access and Interventional segments.
OMCL Stock Soars on Q3 Earnings & Revenue Beat, '24 EPS View Raised
by Zacks Equity Research
Omnicell continues its trend of impressive results in the third quarter of 2024.
Envista Stock Climbs on Q3 Earnings and Revenue Beat, Margins Crash
by Zacks Equity Research
NVST delivers better-than-expected top and bottom-line performance in the third quarter of 2024.
Cigna Q3 Earnings Beat on Client Wins & Specialty Business Strength
by Zacks Equity Research
CI's strong third-quarter results benefit from a strong Evernorth Health Services segment. Higher expenses partially offset the positives.
Is Brainsway (BWAY) Stock Outpacing Its Medical Peers This Year?
by Zacks Equity Research
Here is how Brainsway Ltd. Sponsored ADR (BWAY) and Intuitive Surgical, Inc. (ISRG) have performed compared to their sector so far this year.
ZBH Stock Up Despite Q3 Earnings Miss, 2024 View Narrowed
by Zacks Equity Research
Zimmer Biomet delivers strong performance across segments and regions in the third quarter of 2024.
Centene Q3 Earnings Beat on Growth in Marketplace Business Line
by Zacks Equity Research
CNC's Q3 results benefit from growth in premiums, driven by strong product positioning. Despite higher revenues, declines in Medicaid membership and increased expenses weigh on profitability.
Universal Health Q3 Earnings Miss on Elevated Operating Costs
by Zacks Equity Research
UHS' Q3 results suffer from rising operating costs in salaries, wages and benefits, and supplies, impacting profitability. Nevertheless, strong revenue growth and increased admissions partly offset the downside.
ResMed's Stock Rises on Q1 Earnings and Revenue Beat, Margins Expand
by Zacks Equity Research
RMD's stellar first-quarter fiscal 2025 results reflect the ongoing momentum and strong execution across all areas of its business.
ALGN Q3 Earnings Top Estimates, Revenues Miss, Stock Falls
by Zacks Equity Research
Align Technology reports third-quarter 2024 revenue growth. This can be mostly attributed to a robust performance by the Imaging Systems & CAD/CAM Services business segment.
Intuitive Surgical (ISRG) Is Considered a Good Investment by Brokers: Is That True?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Intuitive Surgical (ISRG) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Thermo Fisher Q3 Earnings Top Estimates, Revenues Miss, Stock Dips
by Zacks Equity Research
In the third quarter of 2024, TMO continued to advance its growth strategy and trusted partner status with customers.
Company News for Oct 21, 2024
by Zacks Equity Research
Companies in The News Are: ISRG, SLB, PLTR, HAL
Intuitive Surgical, Inc. (ISRG) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Intuitive Surgical (ISRG) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Compared to Estimates, Intuitive Surgical (ISRG) Q3 Earnings: A Look at Key Metrics
by Zacks Equity Research
While the top- and bottom-line numbers for Intuitive Surgical (ISRG) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Intuitive Surgical Q3 Earnings Beat, Procedures Robust
by Zacks Equity Research
ISRG's third-quarter results reflect a healthy demand for procedures. Higher pricing boosts procedure sales. An improvement in margins buoys well.
Netflix, Intuitive Beat Q3 Earnings Easily
by Mark Vickery
Earnings of $5.40 per share for NFLX surged past the $5.09 in the Zacks consensus, demonstrating +45% growth year over year.
Intuitive Surgical, Inc. (ISRG) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Intuitive Surgical (ISRG) delivered earnings and revenue surprises of 11.52% and 1.17%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Small-Cap Russell Dominates Stock Market Hump Day
by Mark Vickery
Many stocks in the Russell 2000 are small community banks, and we've seen big banks perform very well overall so far in Q3 earnings season.
Will Intuitive Surgical (ISRG) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Intuitive Surgical (ISRG) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Should ISRG Stock Be Part of Your Portfolio Ahead of Q3 Earnings?
by Zacks Equity Research
Intuitive Surgical's third-quarter results are likely to reflect solid performance in the company's Instruments & Accessories segment. Improving margins buoy optimism.